Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory subunit 16B (PPP1R16B) is a membrane-associated protein containing five ankyrin repeats, a protein phosphatase 1-interacting domain, and a CAAX box at its C-terminus. It functions as a regulator of protein phosphatase 1 (PP1), positively regulating pulmonary endothelial cell barrier function and participating in angiogenesis, endothelial cell proliferation, and filopodia extension. PPP1R16B modulates the activity of PP1 by facilitating dephosphorylation events crucial for cellular signaling, especially in vascular tissues, and protects the endothelial barrier against lipopolysaccharide-induced leakage. Synthesis of PPP1R16B is inhibited by transforming growth factor beta-1 (TGF-beta1), identifying it as a downstream target in TGF-beta1 signaling. Multiple isoforms are produced by alternative splicing. Disease association is primarily described with primary ciliary dyskinesia, with possible roles in pulmonary and vascular pathophysiology. No direct drug interactions, biomarker usage, or established safety concerns are currently listed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 16B (PPP1R16B).